![Single-Dose Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated With Cisplatin Therapy: Randomized, Double-Blind Study Protocol--EASE]()
Single-Dose Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated With Cisplatin Therapy: Randomized, Double-Blind Study Protocol--EASEGrunberg, S.; Chua, D.; Maru, A.; Dinis, J.; DeVandry, S.; Boice, J. A.; Hardwick, J. S.; Beckford, E.; Taylor, A.; Carides, A.; Roila, F.; Herrstedt, J. · Journal of Clinical Oncology · 2011